Inicio › Cáncer de pulmón › Indiana
Ensayos clínicos de Cáncer de pulmón en Indiana
24 estudios sobre Cáncer de pulmón buscan participantes en Indiana.
Ciudades en Indiana
Texto oficial del estudio (inglés)
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- IU Health West Hospital, Avon
- IU Health North Hospital, Carmel
- Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis
- y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06498635Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- Northwest Cancer Center - Crown Point, Crown Point
- Northwest Oncology LLC, Dyer
- Parkview Regional Medical Center, Fort Wayne
- y 7 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT04267848Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
- Northwest Cancer Center - Crown Point, Crown Point
- Northwest Oncology LLC, Dyer
- Northwest Cancer Center - Hobart, Hobart
- y 5 más
ReclutandoFase 3
Edades de 70 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06096844A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
- Parkview Research Center at Parkview Regional Medical Center ( Site 0089), Fort Wayne
- Indiana University Health Arnett Cancer Center ( Site 0076), Lafayette
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT06312137Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Reid Health, Richmond
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT05334069Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
- Northwest Cancer Center - Crown Point, Crown Point
- Northwest Oncology LLC, Dyer
- Northwest Cancer Center - Hobart, Hobart
- y 5 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT04181060A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Parkview Research Center at Parkview Regional Medical Center, Fort Wayne
- Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
- Franciscan Health, Indianapolis
- y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06119581Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)
- Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne
- Indiana University Health University Hospital, Indianapolis
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT06712316Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
- UChicago Medicine Northwest Indiana, Crown Point
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 oct 2026 · NCT06287775Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
- Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 oct 2026 · NCT02984761Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
- University of Indiana, Indianapolis
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 oct 2026 · NCT06922591A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Franciscan Health, Munster
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 oct 2026 · NCT07154290A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
- Northwest Cancer Centers, Dyer
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 19 oct 2026 · NCT06244771Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
- Fort Wayne Medical Oncology and Hematology, Inc, Fort Wayne
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 oct 2026 · NCT06712355Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
- Northwest Cancer Center - Crown Point, Crown Point
- Northwest Oncology LLC, Dyer
- Saint Mary Medical Center, Hobart
- y 5 más
ReclutandoFase 2
18 Minutes · Todos los sexos · Actualizado el 9 oct 2026 · NCT06031688Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
- Northwest Cancer Center - Crown Point, Crown Point
- Northwest Oncology LLC, Dyer
- Saint Mary Medical Center, Hobart
- y 7 más
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 oct 2026 · NCT06616584Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Community Health Network, Inc, Indianapolis
- Community Health Network, Inc., Indianapolis
- Community Health Network, Inc., Indianapolis
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 oct 2026 · NCT07222566Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Indiana University Simon Comprehensive Cancer Center, Indianapolis
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 1 oct 2026 · NCT06625775Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Community Health Network, Indianapolis
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT06128551Increasing Equity in Lung Cancer Screening
- Eskenazi Health, Indianapolis
ReclutandoSe aceptan voluntarios sanos
Edades de 50 a 80 · Todos los sexos · Actualizado el 10 sept 2026 · NCT06360822Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
- Northwest Cancer Center - Crown Point, Crown Point
- Northwest Oncology LLC, Dyer
- Northwest Cancer Center - Hobart, Hobart
- y 4 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT05624996Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
- Roudebush VA Medical Center, Indianapolis
- Sidney and Lois Eskenazi Hospital, Indianapolis
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 jul 2026 · NCT05889546Integrated Cancer Repository for Cancer Research
- Parkview Research Center, Fort Wayne
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 19 a 110 · Todos los sexos · Actualizado el 29 jun 2026 · NCT02012699Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 abr 2026 · NCT04919382De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.